drugdeliverybusiness2d
Senseonics submits year-long CGM for CE mark
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Should You Buy DexCom Stock Before Feb. 13?
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
drugdeliverybusiness4d
Dexcom establishes direct presence in Italy with CGM launch, ends distro deal with Roche
Dexcom (Nasdaq:DXCM) announced today that it plans to establish a direct presence in Italy, bringing its CGM technology to ...
Healio4d
CGM may lead to lower health care costs for pregnant women with type 1 diabetes
The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...
Hosted on MSN4d
Glucotrack hits trial success for direct blood measuring CGM
The company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...
American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
In the Spring 2024 semester, Glucoguard was invited to participate in the MADO program through our ongoing relationship with ...
Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...
DexCom, Inc. (NASDAQ:DXCM) Given Average Rating of “Moderate Buy” by Brokerages
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...
Flagship Harbor Advisors LLC Purchases Shares of 5,842 DexCom, Inc. (NASDAQ:DXCM)
Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...